Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Int.biotech. (IBT) Share Price

Price 1,085.00p on 15-09-2026 at 17:35:13
Change -35.00p -3.13%
Buy 1,105.00p
Sell 1,085.00p
Last Trade: Sell 1,135.00 at 1,085.00p
Day's Volume: 29,546
Last Close: 1,085.00p
Open: 1,110.00p
ISIN: GB0004559349
Day's Range 1,085.00p - 1,110.00p
52wk Range: 674.00p - 1,215.00p
Market Capitalisation: £343.43m
VWAP: 1,106.17092p
Shares in Issue: 31.65m

Int.biotech. (IBT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 1,135 1,085.00p Uncrossing Trade
16:35:29 - 15-Sep-26
Buy* 90 1,100.00p Ordinary
16:27:10 - 15-Sep-26
Buy* 100 1,099.90p Ordinary
16:27:09 - 15-Sep-26
Buy* 45 1,099.90p Ordinary
16:27:09 - 15-Sep-26
Sell* 4,522 1,099.99p Ordinary
16:26:35 - 15-Sep-26
Buy* 137 1,100.20p Ordinary
16:09:43 - 15-Sep-26
Buy* 750 1,100.2104p Ordinary
15:51:46 - 15-Sep-26
Buy* 250 1,100.2204p Ordinary
15:44:52 - 15-Sep-26
Buy* 440 1,108.98p Ordinary
15:43:16 - 15-Sep-26
Buy* 739 1,100.20p Ordinary
15:39:57 - 15-Sep-26
See more Int.biotech. trades

Int.biotech. (IBT) Share Price History

Time period:
to
Date Open High Low Close Volume
15th Sep 2026 (Tue) 1,110.00 1,110.00 1,085.00 1,085.00 29,546
14th Sep 2026 (Mon) 1,095.00 1,120.00 1,095.00 1,120.00 115,604
11th Sep 2026 (Fri) 1,090.00 1,120.00 1,090.00 1,115.00 84,210
10th Sep 2026 (Thu) 1,110.00 1,115.00 1,095.00 1,110.00 64,875
9th Sep 2026 (Wed) 1,120.00 1,120.00 1,105.00 1,110.00 94,138
8th Sep 2026 (Tue) 1,125.00 1,125.00 1,095.00 1,105.00 68,492
7th Sep 2026 (Mon) 1,130.00 1,130.00 1,105.00 1,110.00 58,907
4th Sep 2026 (Fri) 1,125.00 1,130.00 1,115.00 1,120.00 52,913
3rd Sep 2026 (Thu) 1,130.00 1,145.00 1,125.00 1,125.00 158,561
2nd Sep 2026 (Wed) 1,130.00 1,135.00 1,115.00 1,115.00 51,216
1st Sep 2026 (Tue) 1,130.00 1,130.00 1,105.00 1,120.00 50,991
31st Aug 2026 (Mon) 1,135.00 1,135.00 1,135.00 1,135.00 0
28th Aug 2026 (Fri) 1,130.00 1,140.00 1,125.00 1,135.00 76,598
27th Aug 2026 (Thu) 1,135.00 1,140.00 1,130.00 1,140.00 37,986
26th Aug 2026 (Wed) 1,125.00 1,135.00 1,125.00 1,135.00 85,792
25th Aug 2026 (Tue) 1,105.00 1,130.00 1,105.00 1,130.00 82,651
24th Aug 2026 (Mon) 1,110.00 1,125.00 1,100.00 1,105.00 77,108
21st Aug 2026 (Fri) 1,125.00 1,125.00 1,115.00 1,120.00 184,369
20th Aug 2026 (Thu) 1,135.00 1,135.00 1,110.00 1,130.00 80,193
19th Aug 2026 (Wed) 1,105.00 1,135.00 1,105.00 1,130.00 102,262
18th Aug 2026 (Tue) 1,085.00 1,105.00 1,085.00 1,105.00 60,920
17th Aug 2026 (Mon) 1,090.00 1,090.00 1,085.00 1,085.00 98,095
See more Int.biotech. price history

Int.biotech. (IBT) Regulatory News

Date Source Headline
15th Sep 2026 12:11 pm RNS Net Asset Value(s)
14th Sep 2026 10:55 am RNS Net Asset Value(s)
11th Sep 2026 11:14 am RNS Net Asset Value(s)
10th Sep 2026 11:24 am RNS Net Asset Value(s)
9th Sep 2026 11:55 am RNS Net Asset Value(s)
8th Sep 2026 11:07 am RNS Net Asset Value(s)
7th Sep 2026 11:46 am RNS Net Asset Value(s)
4th Sep 2026 11:45 am RNS Net Asset Value(s)
3rd Sep 2026 11:43 am RNS Net Asset Value(s)
2nd Sep 2026 11:44 am RNS Net Asset Value(s)
See more Int.biotech. regulatory news

Int.biotech. (IBT) Share News

UK dividends calendar - next 7 days

14th Aug 2026 12:57

Read More

UK dividends calendar - next 7 days

16th Jul 2026 14:44

Read More

IBT company Crinetics to be acquired by Vertex for USD10 billion

7th Jul 2026 19:11

(Alliance News) - International Biotechnology Trust PLC on Tuesday said its portfolio company, Crinetics Pharmaceuticals Inc, entered a deal to be acquired by Vertex Pharmaceuticals Inc in a deal worth USD10 billion. Read More

IN BRIEF: International Biotech highlights deal for investee Apogee

22nd Jun 2026 20:07

International Biotechnology Trust PLC - invests in biotechnology companies - Notes announcement that investee company Apogee Therapeutics is to be acquired by AbbVie Inc. Apogee shareholders will receive USD135.11 per share in cash at closing. As at close of business on Friday, Apogee represented around 0.41% of IBT's net asset value. IBT Portfolio Managers Ailsa Craig and Marek Poszepczynski say: "The biotech M&A boom shows no signs of slowing, with deal flow running ahead of last year's pace. The latest deal represents the seventh acquisition within the IBT portfolio in 2026 so far, compared to three acquisitions at the same stage last year, with the total value of the companies acquired also up 9%. This demonstrates the success of our investment strategy." Read More

EARNINGS: Griffin Mining revenue jumps; Andrews Sykes holds payout

12th May 2026 12:48

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

See more Int.biotech. news
FTSE 100 Latest
Value10,658.13
Change-39.44

Login to your account

Forgot Password?

Not Registered